Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Regeneron (REGN) shares decreased 4% after announcing an expanded immunology alliance with Sanofi. The terms of the deal left the economics for their drug Dupixent unchanged. Sanofi will pay Regeneron $1 billion upfront.
French drugmaker Sanofi EURONEXT:SAN said on Thursday it would pay US partner Regeneron NASDAQ:REGN $1 billion upfront and up to $7 billion more in milestone payments to add four next-generation, long-acting immunology antibodies to the partnership behind their blockbuster eczema drug Dupixent.The…
On Monday, AstraZeneca (NASDAQ: AZN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary AstraZeneca reported a 6% growth in total revenue for the fi